Topics

Michael Wong is an Emeritus Board Member of the Harvard Business School Healthcare Alumni Association.

Articles

Harvard Business School Professor Amy C. Edmondson talks about achieving psychological safety in the workplace.

The Role of Fearless Organizations in Global Crises

From supply-chain and clinical-trial disruptions in Ukraine and Russia, to decisions to halt investment or maintain operations, global implications for industry and pharmaceutical production are immense.

Ukraine Invasion Challenges Biopharma Research and Operations

Scott Howell is Chief Strategy Officer, US Pharmaceuticals, at Novartis.

Ray Pressburger is Managing Director, Life Sciences Strategy at Accenture. 

The life sciences industry is at an inflection point, with pressures around pricing, patient access, and affordability converging with the cost of increasingly complex and personalized medicines to make today’s economics unsustainable. Scott Howell and Ray Pressburger discuss what can be done to help solve these challenges across the industry.

An Economic Path Forward: Thoughts on an Industry Inflection Point

Michael Christel is Group Managing Editor of Pharmaceutical Commerce, Pharmaceutical Executive, and Applied Clinical Trials. He can be reached at mchristel@mjhlifesciences.com.

 Introducing our first deep dive into pharma's indispensable partner—the 3PL

A Lowdown on Logistics

Can technology really build trust in pharmaceutical supply chains?

Striving for Authentic, Transparent Track and Trace

A prescription for making the pharma supply chain more resilient, reliable and disruption-proof

Right product, right place, right away

The promise of advanced AI in transforming the value picture in drug development

AI’s predictive power on the big stage

Hurricane Ida reminds us of the importance of an effective supply chain

When the extreme hits home

Gains in temperature-controlled logistics, accelerated by the pandemic, have reshaped the landscape for global pharma distribution

The Future Heats Up Due to Cold Chain

Taking stock of lessons learned during pandemic—and opportunities to grow stronger

Opinion